TY - JOUR
T1 - Complement activation by Coccidioides immitis
T2 - In vitro and clinical studies
AU - Galgiani, J. N.
AU - Yam, P.
AU - Petz, L. D.
AU - Williams, P. L.
AU - Stevens, D. A.
PY - 1980
Y1 - 1980
N2 - Mycelial- or spherule-phase derivatives of Coccidioides immitis caused a decrease in vitro of total hemolytic complement in serum from a nonsensitized person. Activation involved both classic and alternative pathways as shown by depression of hemolytic C4 and by generation of products of activation of components C3, C4, and factor B. In addition, functional complement activity or immunoreactive levels of complement components or both were measured in 23 patients with self-limited or disseminated coccidioidomycosis. Low total hemolytic complement was found in nine, usually during the early phase of primary illness, and was transient. Hemolytic C4 was low, and the effect of inulin to decrease complement levels was blunted, suggesting both classic and alternative pathways may be deficient. However, associated depression of immunoreactive levels of components assayed (C3, C4, C5, factor B, and properdin) was not consistently found. This disparity raises the possibility of enhanced in vitro inactivation analogous to activation by immune complexes.
AB - Mycelial- or spherule-phase derivatives of Coccidioides immitis caused a decrease in vitro of total hemolytic complement in serum from a nonsensitized person. Activation involved both classic and alternative pathways as shown by depression of hemolytic C4 and by generation of products of activation of components C3, C4, and factor B. In addition, functional complement activity or immunoreactive levels of complement components or both were measured in 23 patients with self-limited or disseminated coccidioidomycosis. Low total hemolytic complement was found in nine, usually during the early phase of primary illness, and was transient. Hemolytic C4 was low, and the effect of inulin to decrease complement levels was blunted, suggesting both classic and alternative pathways may be deficient. However, associated depression of immunoreactive levels of components assayed (C3, C4, C5, factor B, and properdin) was not consistently found. This disparity raises the possibility of enhanced in vitro inactivation analogous to activation by immune complexes.
UR - http://www.scopus.com/inward/record.url?scp=0018825113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018825113&partnerID=8YFLogxK
M3 - Article
C2 - 6901703
AN - SCOPUS:0018825113
SN - 0019-9567
VL - 28
SP - 944
EP - 949
JO - Infection and Immunity
JF - Infection and Immunity
IS - 3
ER -